Stroke (incidence rate per 1000 women-years was 1.43 for tamoxifen vs 1 for placebo) and PE (incidence rate per 1000 women-years was 0.75 for tamoxifen vs 0.25 for placebo) have been reported with tamoxifen use in women with ductal carcinoma in situ or at high risk for breast cancer in a randomized, double-blind, breast cancer prevention trial (NSABP P-1 trial)
GLP-1 Receptor Agonists May Modestly Reduce Risk of Fourteen Obesity-Related Cancers for People With Diabetes
Sioutas: IIH is relatively rare, but for those who have it, the impact on quality of life can be profound
But you wont start to see those six-pack abs until weight loss kicks in
Suppressing glucagon They decrease levels of glucagon, a hormone that normally signals the liver to release stored glucose, lowering fasting blood sugar levels
Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway